OHRP stock forecast
Our latest prediction for Ohr Pharmaceutical, Inc.'s stock price was made on the April 10, 2017 when the stock price was at 0.68$.
In the short term (2weeks), OHRP's stock price should outperform the market by 7.35%. During that period the price should oscillate between -9.22% and +23.06%.
In the medium term (3months), OHRP's stock price should outperform the market by 14.87%. During that period the price should oscillate between -21.25% and +70.55%.Get email alerts
About Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. engages in the development of novel therapeutics and delivery technologies for the treatment of ocular disease. Its product portfolio includes squalamine and SKS sustained release technology. The company was founded by Irach B. Taraporewala in 2008 and is headquartered in New York, NY.
At the moment the company doesn't generate any revenue.
On its last earning announcement, the company reported a loss of -0.20$ per share.
The book value per share is 0.30$
Three months stock forecastApril 10, 2017
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|